Trial intelligence / Profile preview

Impact of Cannabis on Opioid Self-Administration

NCT07668635Phase 1Not yet recruiting

Start
Nov 2026
Primary completion
Jul 2030
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in opioid use disorder (OUD) comparing Active Cannabis with Placebo Cannabis (2 arms). Primary endpoint: Number of Opioid Self-Administration Trials Completed at 6.5 weeks. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

cannabis
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT07668635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07668635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call